Your browser doesn't support javascript.
loading
Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.
Ueda, Daisuke; Ito, Masaoki; Tsutani, Yasuhiro; Giménez-Capitán, Ana; Román-Lladó, Ruth; Pérez-Rosado, Ana; Aguado, Cristina; Kushitani, Kei; Miyata, Yoshihiro; Arihiro, Koji; Molina-Vila, Miguel Angel; Rosell, Rafael; Takeshima, Yukio; Okada, Morihito.
Afiliação
  • Ueda D; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, Japan.
  • Ito M; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, Japan.
  • Tsutani Y; Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
  • Giménez-Capitán A; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, Japan.
  • Román-Lladó R; Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
  • Pérez-Rosado A; Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
  • Aguado C; Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
  • Kushitani K; Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
  • Miyata Y; Department of Pathology, Graduate School of Biomedical & Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Arihiro K; Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Kasumi 1-2-3, Minami-ku, Hiroshima, Japan.
  • Molina-Vila MA; Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima, Japan.
  • Rosell R; Pangaea Oncology, Laboratory of Molecular Biology, Quirón-Dexeus University Institute, Barcelona, Spain.
  • Takeshima Y; Laboratory of Cellular and Molecular Biology, Institute for Health Science Research Germans Trias I Pujol (IGTP), Badalona, Spain.
  • Okada M; Institute of Oncology Rosell (IOR), Quirón-Dexeus University Institute, Barcelona, Spain.
J Cancer Res Clin Oncol ; 147(12): 3709-3718, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33796913

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma Mucinoso / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adenocarcinoma Mucinoso / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article